AIPT - Precision Therapeutics Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
1.0201
-0.0098 (-0.95%)
As of 12:16PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.0299
Open1.0200
Bid1.0200 x 2900
Ask1.0400 x 1000
Day's Range0.9875 - 1.0357
52 Week Range0.8100 - 2.5000
Volume163,756
Avg. Volume317,148
Market Cap12.041M
Beta0.66
PE Ratio (TTM)N/A
EPS (TTM)-1.0750
Earnings DateAug 13, 2018 - Aug 17, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire19 days ago

    Precision Therapeutics Launches New Website

    Precision Therapeutics Inc. (AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that it has launched a new website: www.precisiontherapeutics.com. It has a clean uncluttered design, improved functionality and enhanced content that better reflects the Company’s strategy to develop highly customizable assessment methods for cancer patients. Dr. Carl Schwartz, CEO of Precision Therapeutics, commented "We are pleased to launch our new website which provides robust information for the pharmaceutical, biotech and diagnostic industries, as well as for investors, partners and media.

  • GlobeNewswirelast month

    Precision Therapeutics Reports First Quarter 2018 Financial Results

    Precision Therapeutics Inc. (AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today financial results for the three months ended March 31, 2018 and provided a business update.

  • GlobeNewswirelast month

    Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018

    Precision Therapeutics Inc. (AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery and producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announced today that it expects to secure its first European sales of the STREAMWAY® Systems in the second half of 2018. Based on the interest generated to date, and the stage of negotiations with several potential customers, the Company expects these sales to generate meaningful revenues. Earlier this year, the Company opened its new European headquarters in Belgium, led by Jean-Paul Rasschaert, Vice President of International Sales, to drive international sales for the STREAMWAY System.

  • GlobeNewswirelast month

    Precision Therapeutics to Hold Business Update Conference Call on May 15, 2018

    Precision Therapeutics Inc. (AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that management will report its financial results for the fiscal first quarter of 2018 on May 15, 2018 after U.S. markets close. To access the conference call, U.S.-based listeners should dial (800) 263 0877 and international listeners should dial +1 (646) 828-8143. To be added to the Precision Therapeutics’ database, please email Info@MoneyInfo-llc.com with your email address.  This is solely for the use of Precision Therapeutics and will not be sold or distributed to third parties.

  • GlobeNewswire2 months ago

    Precision Therapeutics, Inc. Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares

    Precision Therapeutics Inc. (AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that it has signed an LOI to acquire the remainder of the equity in Helomics Corporation® not currently owned by Precision Therapeutics. Under the terms of the agreement, a newly formed, wholly owned subsidiary of Precision Therapeutics will merge with and into Helomics Corporation, thereby increasing Precision’s equity stake in Helomics from 25% to 100%.

  • GlobeNewswire2 months ago

    Precision Therapeutics, Inc. Engages Richard Gabriel to Drive Business Development Strategy for its TumorGenesis Subsidiary

    MINNEAPOLIS, April 09, 2018-- Precision Therapeutics Inc., formerly Skyline Medical, a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that ...

  • GlobeNewswire2 months ago

    CORRECTING and REPLACING - Precision Therapeutics Releases Highlights from FY 2017 Business Update Call

    In a release issued under the same headline earlier today by Precision Therapeautics, please note that the forward-looking statements paragraph was missing. MINNEAPOLIS, April 04, 2018-- Precision Therapeutics ...

  • GlobeNewswire2 months ago

    Precision Therapeutics is the First Company to Grow Cancer Cells in the Lab That React Like Tumors Inside the Body -- CEOLIVE.TV

    ORLANDO, FL, April 04, 2018-- CEOLive.TV, a news organization that highlights leading CEOs, companies, and industry experts for investors, today released a video interview with Dr. Carl Schwartz, CEO of ...

  • GlobeNewswire2 months ago

    Precision Therapeutics Releases Highlights from FY 2017 Business Update Call

    MINNEAPOLIS, April 04, 2018-- Precision Therapeutics Inc., formerly Skyline Medical, a company focused on applying artificial intelligence to personalized medicine and drug discovery, today released highlights ...

  • GlobeNewswire3 months ago

    Precision Therapeutics Reports Fiscal Year 2017 Financial Results

    MINNEAPOLIS, April 02, 2018-- Precision Therapeutics Inc., formerly Skyline Medical, a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today financial ...

  • GlobeNewswire3 months ago

    Precision Therapeutics Announces Record STREAMWAY® System Sales in the First Three Months of 2018

    MINNEAPOLIS, March 29, 2018-- Precision Therapeutics Inc., today provided a sales update from its Skyline Medical division, producer of the FDA-approved STREAMWAY System for automated, direct-to-drain ...

  • GlobeNewswire3 months ago

    Precision Therapeutics to Hold Business Update Conference Call on April 2, 2018

    MINNEAPOLIS, March 26, 2018-- Precision Therapeutics Inc., formerly Skyline Medical, a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that ...